31 Mar 2019
Assets1,475.40
Total Income886.87
EBITDA248.16
Profit After Tax195.59
NET Worth88.13
Reserves and Surplus86.17
Total Borrowing0.02
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Revenue1,885.98₹ Cr · +21.7% vs prior year
EBITDA591.89₹ Cr · +22.3% vs prior year
PAT351.58₹ Cr · +12.3% vs prior year
Assets1,997.08₹ Cr · +15.7% vs prior year
Net Worth752.75₹ Cr · +87.4% vs prior year
Borrowing0.00₹ Cr · -100.0% vs prior year
3-year financial trendRevenue / EBITDA / PAT
₹ crore31 Mar 2020
Assets1,725.60
Total Income1,549.30
EBITDA483.95
Profit After Tax313.10
NET Worth401.69
Reserves and Surplus399.73
Total Borrowing0.02
31 Mar 2021
Assets1,997.08
Total Income1,885.98
EBITDA591.89
Profit After Tax351.58
NET Worth752.75
Reserves and Surplus750.79
Total Borrowing0.00
IPO UPDATE ALERTS
Register for IPO Updates →Track Glenmark Life Sciences without missing an update
Register for subscription, GMP, allotment and listing notifications.